The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)July 21, 2026 — For a long time, many people have claimed that using a mobile phone can cause brain cancer. These fears were so widespread that the World Health Organization commissioned teams to conduct 13 reviews aimed at establishing whether electromagnetic waves, such as those that enable mobile phones to work, had any health effects.
July 21, 2026 — The U. S.
July 21, 2026 — Gold prices continue to trade within a relatively narrow range, struggling to build enough momentum to rise above $4,100 an ounce. However, according to Saxo Bank’s Head of Commodity Strategy, Ole Hansen, the current consolidation should not be viewed as a sign of weakness.
July 21, 2026 — Datavault AI (NASDAQ: DVLT) announced that Fiserv (NASDAQ: FISV) will serve as the exclusive embedded financial services and payments provider for the company’s digital marketplaces and exchanges. Through Fiserv’s Embedded Finance platform, Datavault AI will integrate banking, payment and card programs into its ecosystem, supporting financial transactions across platforms including its planned NIL Exchange and patented Information Data Exchange(R).
July 21, 2026 — Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.
July 21, 2026 — This article has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) announced it has completed enrollment in its pivotal Phase 3 APPROACH trial evaluating HLP003 as an adjunctive treatment for adults with moderate to severe major depressive disorder who have not achieved an adequate response to antidepressant therapy.
July 21, 2026 — This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.
July 21, 2026 — Datavault AI (NASDAQ: DVLT) a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, outlined its strategic priorities for the third quarter of 2026, highlighting commercialization of its previously announced Project Qestrel ($QEST) token program, continued expansion of its SanQtum edge AI infrastructure and advancement of specialized digital asset exchange platforms. The company also expects to complete several previously announced transactions during the quarter, including the CyberCatch acquisition, the acquisition of NYIAX Inc.
July 21, 2026 — BOXABL is advancing a factory-based approach to housing that seeks to standardize production and improve cost efficiency in a traditionally fragmented industry. The company is targeting a large addressable market supported by a significant housing supply gap and long-term affordability challenges.
July 20, 2026 — NUBURU (NYSE American: BURU) announced the closing of its previously announced best-efforts public offering, raising approximately $38. 0 million in gross proceeds before fees and expenses.
July 20, 2026 — NUBURU (NYSE American: BURU) announced the closing of its previously announced best-efforts public offering, raising approximately $38. 0 million in gross proceeds before fees and expenses.
July 20, 2026 — Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.
July 20, 2026 — The global electric vehicle (EV) market is entering a new stage of growth as manufacturers focus on making electric cars more affordable, efficient, and widely available. A new analysis by Frost & Sullivan shows that the next phase of EV development will be shaped by lower costs, better technology, stronger supply chains, and improved charging infrastructure.
July 20, 2026 — Metal prices retreated as the week ended amid an escalation in the hostilities between Iran and the U. S.
July 20, 2026 — The current administration’s approach to clean energy policy has led to the cancellation of $83 billion worth of renewables projects. Unlike the Biden administration, which prioritized and invested in sustainability, the Trump administration has taken the complete opposite stance.
July 20, 2026 — Earth Science Tech, a strategic holding company in the healthcare, pharmacy, and telemedicine sector, is distinct from other OTC listed companies based on its record of strong results, hard real estate assets, vertical integration, and robust corporate structure The company has reported year-over-year growth in revenue and gross profits since fiscal year 2024, progress attributable to careful strategic and complementary investments and acquisitions, which have not added debt to its balance sheet Its acquisition of Avenvi created a subsidiary that develops, manages, and finances real estate and owns property that houses ETST’s Texas pharmacy Investopedia lists the lack of reliable information about listed companies as one of the primary risks of OTC stocks. This, according to the article, makes it difficult for investors to evaluate and ascertain the “realistic potential” of these stocks (https://ibn.
July 20, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.
July 20, 2026 — VERAXA Biotech (NASDAQ: VRXA) announced it has received Scientific Advice from Germany’s Paul-Ehrlich-Institute regarding the underlying biology and proposed non-clinical development plan for its lead proprietary BiTAC-TCE cancer therapy program. The company said the regulatory feedback provides greater clarity on its proposed development strategy and indicates that the agency understands the biological rationale behind its dual-targeting, conditionally active BiTAC-TCE platform, representing an early step in advancing the program toward clinical development.
July 20, 2026 — Regentis Biomaterials (NYSE American: RGNT) announced that the Japan Patent Office has issued a Notice of Allowance for a patent covering its proprietary organic solvent-free manufacturing process and ready-to-use liquid formulation used in GelrinC(R), the company’s regenerative treatment for articular cartilage injuries. Regentis said the allowance expands its global intellectual property portfolio as it advances GelrinC commercialization in Europe, continues enrollment in its pivotal U.
July 20, 2026 — Knightscope (NASDAQ: KSCP) announced preliminary, unaudited revenue of approximately $9 million for the second quarter ended June 30, 2026, representing growth of more than 200% from $2. 7 million in the year-ago period and marking a quarterly revenue record for the company.